Skip to main content

George Goedesky

George Goedesky has joined Affinity Biosensors as vice president of sales of marketing. He will lead the rollout of the LifeScale AST system for rapid antibiotic susceptibility tests. Most recently, Goedesky led the adoption of the Burker MALDII Biotyper platform in the Americas. The LifeScale AST platform is currently in US clinical trials for identifying targeted therapy for sepsis, Affinity Biosensors said.